Reuters logo
BRIEF-Nantkwest announces FDA grant of orphan drug designation
2017年3月20日 / 上午11点28分 / 8 个月前

BRIEF-Nantkwest announces FDA grant of orphan drug designation

March 20 (Reuters) - Nantkwest Inc:

* Nantkwest announces FDA grant of orphan drug designation for the company’s ank natural killer cell therapy in merkel cell carcinoma Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below